StockData
SCYNEXIS Inc logo

SCYNEXIS Inc (SCYX) stock

SCYXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 13/3072% below fair value
$2.85−0.06 (-2.06%)

Close on Nov 17, 2026Market cap $28.36MP/E –Yield –

Scynexis price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Scynexis's price to sales ratio was 1.8× on Nov 11, 2026, against 9.9× a year earlier. Over the last 5 years it ranged from 0.4× to 37.5×, with a median of 8.5×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 20261.8×−7.3
2025Dec 31, 20259.0×+3.7
2024Dec 31, 20245.4×+4.7
2023Dec 29, 20230.6×−11.6
2022Dec 30, 202212.2×+0.6
2021Dec 31, 202111.6×−256.0
2020Jan 31, 2020267.6×−14.6
2019Dec 31, 2019282.2×+193.4
2018Dec 31, 201888.8×−167.0
2017Dec 29, 2017255.8×−36.2
2016Dec 30, 2016292.0×+223.3
2015Dec 31, 201568.7×+58.7
2014Dec 31, 201410.0×–

More Scynexis figures

See a number that looks wrong?